MoneyWorks4Me

Ipca Laboratories - Quaterly Results

10 Nov 2023 Evaluate
The Revenue for the quarter ended  September 2023 of Rs. 16626.70 millions grew by 11.25 % from Rs. 14945.70 millions.The Net proft of the company remain more or less same to Rs. 1621.30  millions from Rs. 1656.30 millions ,decline by -2.11%.Operating profit surged to 3451.20 millions from the corresponding previous quarter of 3056.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 16626.70 14945.70 11.25 31513.80 29728.80 6.00 58146.20 54383.00 6.92
Other Income 361.40 355.90 1.55 793.00 535.20 48.17 1111.90 529.20 110.11
PBIDT 3451.20 3056.70 12.91 6858.10 5786.20 18.53 10230.40 12910.00 -20.76
Interest 386.40 90.00 329.33 694.00 158.00 339.24 439.20 72.40 506.63
PBDT 3064.80 2966.70 3.31 6164.10 5628.20 9.52 9791.20 12837.60 -23.73
Depreciation 613.50 562.80 9.01 1217.00 1110.40 9.60 2286.30 2096.50 9.05
PBT 2451.30 2403.90 1.97 4947.10 4517.80 9.50 7504.90 10741.10 -30.13
TAX 830.00 747.60 11.02 1660.00 1460.80 13.64 2447.90 2137.40 14.53
Deferred Tax -10.00 6.10 -263.93 20.00 124.80 -83.97 208.40 164.60 26.61
PAT 1621.30 1656.30 -2.11 3287.10 3057.00 7.53 5057.00 8603.70 -41.22
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 20.76 20.45 1.49 21.76 19.46 11.81 17.59 23.74 -25.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..